SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
-22.38%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$174M
AUM Growth
+$174M
(-17%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
14.66%
Top 10 Holdings %
Top 10 Hldgs %
76.37%
Holding
28
New
9
Increased
8
Reduced
2
Closed
–
Top Buys
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$5.6M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
$4.21M |
| 3 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$3.35M |
| 4 |
Aclaris Therapeutics
ACRS
|
$2.71M |
| 5 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$2.09M |
Top Sells
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$938K |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$762K |
Sector Composition
| 1 | Healthcare | 97.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Akero Therapeutics
AKRO
$3.65B
| $1.06M | 0.61% |
+50,000
| New | +$1.06M |
|
|
AMRN
27
Amarin Corp
AMRN
$311M
| $781K | 0.45% |
+9,760
| New | +$781K |
|
28
KALA BIO
KALA
$105M
| $563K | 0.32% |
+1,283
| New | +$563K |
|